| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 170.55 | 1450 |
| Intrinsic value (DCF) | 7.93 | -28 |
| Graham-Dodd Method | 4.18 | -62 |
| Graham Formula | 3.44 | -69 |
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.